Hosted on MSN21h
Needham Upgrades Collegium Pharmaceutical (COLL)Fintel reports that on January 10, 2025, Needham upgraded their outlook for Collegium Pharmaceutical (NasdaqGS:COLL) from ...
Needham analyst upgrades Collegium Pharmaceutical to Buy with a $46 target, citing strong 2025 guidance, growth potential, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback